Director Deals - (GSK)

Luke Miels, Chief Executive Officer, sold post-exercise 4,549 shares in the company on the 9th February 2026 at a price of £22.11. The Director now holds 55,788 shares representing 0.00% of the shares in issue.

Story provided by StockMarketWire.com

Director deals data provided by www.sharesmagazine.co.uk

< Back to list